572650 Sigma-AldrichSU9516 - CAS 666837-93-0 - Calbiochem
A cell-permeable 3-substituted indolinone compound that displays anti-proliferative and proapoptotic properties in tumor cells.
More>> A cell-permeable 3-substituted indolinone compound that displays anti-proliferative and proapoptotic properties in tumor cells. Less<<SU9516 - CAS 666837-93-0 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents.
同义词: 3-[1-(3H-Imidazol-4-yl)-meth-(Z)-ylidene]-5-methoxy-1,3-dihydro-indol-2-one
Recommended Products
概述
Replacement Information |
---|
重要规格表
CAS # | Empirical Formula |
---|---|
666837-93-0 | C₁₃H₁₁N₃O₂ |
价格及供货情况
产品目录编号 | 库存情况 | 包装 | 数量 / 包装 | 价格 | 数量 | |
---|---|---|---|---|---|---|
572650-5MGCN |
|
塑胶安瓿;塑胶针药瓶 | 5 mg |
|
— |
References | |
---|---|
References | Yu, B., et al. 2002. Biochem. Pharmacol. 64, 1091. Lane, M.E., et al. 2001. Cancer Res. 61, 6170. |
Product Information | |
---|---|
CAS number | 666837-93-0 |
ATP Competitive | Y |
Form | Yellow to orange solid |
Hill Formula | C₁₃H₁₁N₃O₂ |
Chemical formula | C₁₃H₁₁N₃O₂ |
Reversible | Y |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Cdk2/A |
Primary Target IC<sub>50</sub> | 22 nM for Cdk2/A; 40 nM for Cdk1/B; 200 nM for Cdk4/D1 |
Purity | ≥95% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | Y |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS |
---|
Safety Information |
---|
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Global Trade Item Number | |
---|---|
产品目录编号 | GTIN |
572650-5MGCN | 04055977266313 |
Documentation
SU9516 - CAS 666837-93-0 - Calbiochem MSDS
职位 |
---|
SU9516 - CAS 666837-93-0 - Calbiochem 分析证书
标题 | 批号 |
---|---|
572650 |
参考
参考信息概述 |
---|
Yu, B., et al. 2002. Biochem. Pharmacol. 64, 1091. Lane, M.E., et al. 2001. Cancer Res. 61, 6170. |